Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China

Media enquiries

First name*

Last name*

Email address*

Phone number*

Media*

Country*

Your message*

*All fields must be filled in

By submitting this form, I agree that any information I give will be used by Ethypharm for the purpose of, and limited to, processing my request. In accordance with the European regulation n°2016/679 of the European Parliament and of the Council of 27 April 2016 relating to the protection of personal data referred to as “GDPR” and effective as of the 25th day of May 2018, I validate that I have the right to access the data concerning me and to have it rectified or deleted by sending a request by selecting “data privacy” on the form on the contact page. To access the page, click here.

Send

Warning

Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China

Media enquiries